Historically, children with food allergies have been treated through strict avoidance of the allergen. Recently, an oral preparation of peanut allergen was approved for immunotherapy in children 4 to 17 years old.
Sandra Hong, MD, Director of Cleveland Clinic’s Food Allergy Center of Excellence, discusses the team’s innovative approaches to early peanut oral immunotherapy and more.
Recent developments in immunotherapy mean that patients with peanut allergies have more options than ever before. Pediatric allergist, Dr. Jacyln Bjelac explains these developments and introduces two peanut oral immunotherapy trials.